Development of molecular subtype specific prognostic marker signature in immune response associated colon cancer through fuzzy based transcriptomic approach

Necla Koçhan, Barış Emre Dayanç
doi: https://doi.org/10.1101/2023.05.18.23290045

Article Information

doi 
https://doi.org/10.1101/2023.05.18.23290045
History 
  • May 24, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Necla Koçhan1 and
  2. Barış Emre Dayanç2,*
  1. 1İzmir Biomedicine and Genome Center (IBG), 35340, İzmir, Turkey
  2. 2Basic Medical Sciences, Faculty of Medicine, Izmir University of Economics, Balcova, Izmir, Turkey
  1. ↵*To whom correspondence should be addressed Barış Emre Dayanç; Address: Izmir University of Economics, Balcova, Izmir, Turkey; Tel: (+90); E-mail: emre.dayanc{at}ieu.edu.tr
Back to top
Posted May 24, 2023.
Download PDF
Data/Code
Email
Development of molecular subtype specific prognostic marker signature in immune response associated colon cancer through fuzzy based transcriptomic approach
Necla Koçhan, Barış Emre Dayanç
medRxiv 2023.05.18.23290045; doi: https://doi.org/10.1101/2023.05.18.23290045
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area